 |
Edit Record
|
 |
|
Return to Portfolio
|
ChiraTechnics -- Chiral Sythesis for Drug Development
|
ChiraTecnics has developed new, more economical, more efficient
proprietary chiral compounds. ChiraTecnics’ intellectual property portfolio of patentable
technologies and trade secrets is derived from unique expertise with asymmetric synthesis
and chiral product analysis making possible four lines of products and services offerings
including a fifth product line that does not involve chiral technologies:
1. Chiral ligand and chemocatalyst platforms in customized commoditized kits for
chiral synthesis delivered in large kg-quantities to large pharma and in small mggram
quantities to pharmaceutical labs, universities and other research
institutions for R&D purposes.
2. Chiral building blocks delivered in large kg- and small mg-quantities to large
pharma for the development of catalyst molecules that accelerate a desired
reaction and optimize pharmaceutical products.
3. Building blocks for fine chemical and catalytic applications.
4. Small scale screening of the broad range of multiple substrates of existing chiral
catalysts.
5. A variety of services related to custom drug synthesis, technology development,
and consultancy.
|
Pharmaceuticals |
|
University of Evora |
|
|
|
|
|